American Century Companies’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $50.8M | Buy |
167,784
+9,478
| +6% | +$2.87M | 0.03% | 670 |
|
2025
Q1 | $52.4M | Buy |
158,306
+21,457
| +16% | +$7.11M | 0.03% | 586 |
|
2024
Q4 | $42.2M | Buy |
136,849
+25,486
| +23% | +$7.86M | 0.02% | 706 |
|
2024
Q3 | $23.6M | Buy |
111,363
+250
| +0.2% | +$53.1K | 0.01% | 952 |
|
2024
Q2 | $31.1M | Buy |
111,113
+13,361
| +14% | +$3.74M | 0.02% | 761 |
|
2024
Q1 | $26.1M | Buy |
97,752
+21,879
| +29% | +$5.84M | 0.02% | 828 |
|
2023
Q4 | $17.6M | Buy |
75,873
+12,264
| +19% | +$2.84M | 0.01% | 920 |
|
2023
Q3 | $9.29M | Buy |
63,609
+14,669
| +30% | +$2.14M | 0.01% | 1091 |
|
2023
Q2 | $11.3M | Buy |
48,940
+19,034
| +64% | +$4.4M | 0.01% | 1004 |
|
2023
Q1 | $7.23M | Buy |
+29,906
| New | +$7.23M | 0.01% | 1119 |
|
2018
Q3 | – | Sell |
-7,691
| Closed | -$2.15M | – | 1320 |
|
2018
Q2 | $2.15M | Buy |
+7,691
| New | +$2.15M | ﹤0.01% | 1012 |
|